Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability 3-09-2024, 19:00

Modelo and Edson Álvarez Team Up to Introduce ‘La Bota Especial’ 18-06-2024, 20:02

The Sanborn Map Company Appoints Sandip Goswami as Managing Director for Sanborn Geophysics ULC 8-02-2024, 19:24